HOME › DRUGS › ATAZANAVIR SULFATE
ACTIVE SUBSTANCE / INN

ATAZANAVIR SULFATE

Brand name(s): EVOTAZ, Reyataz, ATAZANAVIR SULFATE; RITONAVIR, ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE, ATAZANAVIR SULFATE AND RITONAVIR, REYATAZ, ATAZANAVIR SULFATE
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
NDA021567
NDA206041
ACTIVE SUBSTANCE
Atazanavir Sulfate
REGULATORS
FDA · EMA
SPONSORS / MAH
BRISTOL MYERS SQUIBB, MYLAN LABS LTD, EMCURE PHARMS LTD
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
REYATAZNDA206352BRISTOL MYERS SQUIBBPrescription
ATAZANAVIR SULFATEANDA209717AMNEALDiscontinued
ATAZANAVIR SULFATE AND RITONAVIRNDA022282MATRIX LABS LTDNone (Tentative Approval)
ATAZANAVIR SULFATEANDA091611MATRIX LABS LTDNone (Tentative Approval)
ATAZANAVIR SULFATEANDA204806AUROBINDO PHARMAPrescription
ATAZANAVIR SULFATE; RITONAVIRNDA205508EMCURE PHARMS LTDNone (Tentative Approval)
ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINENDA206041MYLAN LABS LTDNone (Tentative Approval)
EVOTAZNDA206353BRISTOLPrescription
REYATAZNDA021567BRISTOL MYERS SQUIBBDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ReyatazBristol-Myers Squibb Pharma EEIGAuthorised01/03/2004HIV Infections

FULL INTELLIGENCE ON ATAZANAVIR SULFATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →